You have read all your free articles, to continue reading subscribe to read the rest of this content.
Gedea Biotech reports that all 24 patients have been treated with its lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis in a proof of concept clinical study. In this open-label, single-armed, multi-center study, promising results have been seen when it comes to clAlready a subscriber Login…
Positive safety and efficacy data from a Phase IIb study evaluating benralizumab has been published, announces AstraZeneca. The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase IIb study evaluating benralizumab, a novel investigational monoclonal antibody, Already a subscriber Login You have read all your free…
Danish Zealand has announced that a milestone has been achieved in the advance of Lixilan towards start of phase III development in the 1st quarter of 2014. The milestone relates to the approval of the first phase III study protocol for Lixilan by a health authority, triggering a USD 15…
Immunovia has announced that the Commercial Test Model study was successful, showing a 95% accuracy, and the company is on track for commercialization of the IMMray PanCan-d commercial biomarker signature. The signature, together with CA19-9, confirmed the same high accuracy from the optimizationAlready a subscriber Login You have read all…
